Site Navigation
Categories:
Norepinephrine reuptake inhibitors
Eli Lilly and Company
Articles needing additional references from August 2008
Articles needing additional references from June 2008
All articles with unsourced statements
Articles with unsourced statements since October 2007

Summary Of: Atomoxetine

of atomoxetine are sold into all countries... atomoxetine is approved for use in children... atomoxetine has great potential in the treatment of... Atomoxetine was originally known as... Atomoxetine is designated chemically as... Atomoxetine is a white solid that exists as a granular powder inside the capsule... controlled clinical trial data for atomoxetine which has identified a statistically significant increased risk of suicidal thoughts with atomoxetine compared to... benefit evaluation of atomoxetine in its licensed indications... warnings about the risk of suicidal behaviour with atomoxetine were added via an Urgent Safety Restriction... two studies that have been performed suggest that atomoxetine has a low to moderate risk for abuse... administer atomoxetine at the doses tested... from saline indicate that atomoxetine produces effects indistinguishable from low doses of cocaine or methamphetamine... The authors concluded that atomoxetine is effective for short term treatment of binge eating disorder... which studied the effectiveness of atomoxetine on adult obese women... Fifteen women were given atomoxetine therapy starting at 25 mg... the atomoxetine group lost an average of 3... Three participants in the atomoxetine group and none in the placebo group lost greater than 5... Atomoxetine and adult attention... label atomoxetine for partial or nonresponse to antidepressants... Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms... Atomoxetine in the Treatment of Binge... Atomoxetine for weight reduction in obese women...

Encyclodia Page On: Atomoxetine

These Are Links To Other Documents
| | IUPAC | CAS number | ATC code | N06 | PubChem | DrugBank | Formula | C | H | N | O | Mol. mass | SMILES | Bioavailability | Protein binding | Metabolism | Hepatic | CYP2D6 | Half life | Excretion | Renal | Pregnancy cat. | AU | US | Legal status | POM | UK | Routes | Eli Lilly's Strattera capsules. | | stimulant | attention-deficit hyperactivity disorder | hydrochloride | Eli Lilly and Company | patent | Generics | Torrent Pharmaceuticals | Ranbaxy Laboratories | Sun Pharmaceuticals | Intas Biopharmaceuticals | United States | | cite | references or sources | reliable sources | Unverifiable | norepinephrine (noradrenaline) reuptake inhibitor | clinical trials | antidepressant | norepinephrine | off-label | dyslexia | dyspraxia | clumsiness | schizoaffective disorder | schizophrenia | schizophrenia | Predominantly Inattentive | Food and Drug Administration | tamoxifen | molecular mass | solubility | pre-gelatinized starch | dimethicone | gelatin | sodium lauryl sulfate | FD&C Blue No. 2 | titanium dioxide | red iron oxide | | cite | references or sources | reliable sources | Unverifiable | erectile dysfunction | retrograde ejaculation | orgasm | ejaculation | citation needed | Eli Lilly and Company | Chemical synapse | pharmacodynamic | pharmacokinetic | black box warnings | dopamine reuptake inhibitors | cocaine | methamphetamine | serotonin | norepinephrine | trade secrets | binge eating disorder | Duke University Medical Center | doi | doi | v | d | Psychoanaleptics | antidepressants | N06A | MAOIs | Isocarboxazid | Iproclozide | Iproniazid | Nialamide | Phenelzine | Tranylcypromine | MAOA | Clorgiline | Minaprine | RIMAs | Brofaromine | Harmaline | Moclobemide | Toloxatone | MAOB | Rasagiline | Selegiline | Pargyline | RIs | S RI | SS RI | Alaproclate | Citalopram | Dapoxetine | Escitalopram | Femoxetine | Fluoxetine | Fluvoxamine | Paroxetine | Sertraline | Vilazodone | Zimelidine | TCAs | Tetras | Cianopramine | Clomipramine | Nefazodone | Trazodone | N RI | A RI | Maprotiline | Nisoxetine | Reboxetine | Viloxazine | TCAs | Tetras | Amoxapine | Butriptyline | Desipramine | Lofepramine | Dibenzepin | Dosulepin | Doxepin | Imipramine | Iprindole | Melitracen | Nortriptyline | Protriptyline | Trimipramine | D RI | Medifoxamine | Phenmetrazine | Vanoxerine | TCAs | Amineptine | SN RI | Bicifadine | Desvenlafaxine | Duloxetine | Milnacipran | Nefazodone | Venlafaxine | TCAs | Amitriptyline | ND RI | Bupropion | Nomifensine | SND RI | Brasofensine | Diclofensine | Tesofensine | SSREs | Tianeptine | AAs | Tetras | Mianserin | Mirtazapine | v | d | Psychoanaleptics | psychostimulants | ADHD | nootropics | N06B | sympathomimetics | Amphetamine | Amphetaminil | Dextroamphetamine | Dextromethamphetamine | Fencamfamine | Fenozolone | Fenethylline | Methylphenidate | Mesocarb | Pemoline | Pipradrol | Prolintane | Xanthine | Caffeine | Propentofylline | Glutamate receptor | Racetams | Aniracetam | Nefiracetam | Oxiracetam | Phenylpiracetam | Piracetam | Pramiracetam | Ampakines | CX-516 | CX-546 | CX-614 | CX-691 | CX-717 | IDRA-21 | LY-404,187 | LY-503,430 | PEPA | Benzhydryl compounds | Adrafinil | Armodafinil | Modafinil | Histamine H3 receptor | antagonists | A-349,821 | ABT-239 | Ciproxifan | GSK-189,254 | GABAA | α5 | inverse agonists | α5IA | L-655,708 | Acetylcarnitine | Citicoline | Cyprodenate | Ensaculin | Idebenone | Ispronicline | Deanol | Dimebon | Fipexide | Leteprinim | Linopirdine | Meclofenoxate | Nizofenone | Pirisudanol | Pyritinol | Sulbutiamine | Taltirelin | Tricyanoaminopropene | Vinpocetine | Categories | Norepinephrine reuptake inhibitors | Eli Lilly and Company | Articles needing additional references from August 2008 | Articles needing additional references from June 2008 | All articles with unsourced statements | Articles with unsourced statements since October 2007 |
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Atomoxetine".